Assertio Therapeutics Stock Price History
| ASRT Stock | USD 1.01 0.07 7.45% |
Below is the normalized historical share price chart for Assertio Therapeutics extending back to December 02, 1997. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Assertio Therapeutics stands at 1.01, as last reported on the 26th of November, with the highest price reaching 1.05 and the lowest price hitting 0.94 during the day.
If you're considering investing in Assertio Stock, it is important to understand the factors that can impact its price. Assertio Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0268, which signifies that the company had a -0.0268% return per unit of risk over the last 3 months. Assertio Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Assertio Therapeutics' Mean Deviation of 3.29, risk adjusted performance of (0.03), and Standard Deviation of 4.6 to double-check the risk estimate we provide.
At this time, Assertio Therapeutics' Common Stock Shares Outstanding is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 336.5 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 11.1 K in 2024. . At this time, Assertio Therapeutics' Price Earnings To Growth Ratio is comparatively stable compared to the past year. Price To Operating Cash Flows Ratio is likely to gain to 1.61 in 2024, whereas Price Book Value Ratio is likely to drop 0.52 in 2024. Assertio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of November 1997 | 200 Day MA 1.0904 | 50 Day MA 1.1284 | Beta 0.835 |
Assertio |
Sharpe Ratio = -0.0268
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ASRT |
Estimated Market Risk
| 4.63 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Assertio Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Assertio Therapeutics by adding Assertio Therapeutics to a well-diversified portfolio.
Price Book 0.7388 | Enterprise Value Ebitda 4.0278 | Price Sales 0.7668 | Shares Float 83.7 M | Wall Street Target Price 3.15 |
Assertio Therapeutics Stock Price History Chart
There are several ways to analyze Assertio Stock price data. The simplest method is using a basic Assertio candlestick price chart, which shows Assertio Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 19, 2024 | 1.35 |
| Lowest Price | November 15, 2024 | 0.81 |
Assertio Therapeutics November 26, 2024 Stock Price Synopsis
Various analyses of Assertio Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Assertio Stock. It can be used to describe the percentage change in the price of Assertio Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Assertio Stock.| Assertio Therapeutics Price Rate Of Daily Change | 1.07 | |
| Assertio Therapeutics Price Daily Balance Of Power | 0.64 | |
| Assertio Therapeutics Price Action Indicator | 0.05 |
Assertio Therapeutics November 26, 2024 Stock Price Analysis
Assertio Stock Price History Data
The price series of Assertio Therapeutics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 0.54 with a coefficient of variation of 11.8. The prices are distributed with arithmetic mean of 1.11. The median price for the last 90 days is 1.13. The company had 1:4 stock split on 18th of May 2021.| Open | High | Low | Close | Volume | ||
11/26/2024 | 0.94 | 1.05 | 0.94 | 1.01 | ||
| 11/25/2024 | 0.94 | 1.05 | 0.94 | 1.01 | 711,645 | |
| 11/22/2024 | 0.95 | 0.99 | 0.93 | 0.94 | 698,979 | |
| 11/21/2024 | 0.95 | 0.97 | 0.90 | 0.97 | 743,557 | |
| 11/20/2024 | 0.98 | 1.00 | 0.93 | 0.95 | 410,571 | |
| 11/19/2024 | 0.84 | 1.08 | 0.84 | 0.97 | 1,971,625 | |
| 11/18/2024 | 0.83 | 0.85 | 0.79 | 0.84 | 676,379 | |
| 11/15/2024 | 0.83 | 0.84 | 0.78 | 0.81 | 1,027,245 | |
| 11/14/2024 | 0.86 | 0.88 | 0.83 | 0.84 | 454,014 | |
| 11/13/2024 | 0.87 | 0.88 | 0.85 | 0.86 | 734,866 | |
| 11/12/2024 | 0.94 | 0.97 | 0.82 | 0.85 | 1,709,265 | |
| 11/11/2024 | 0.90 | 1.00 | 0.90 | 0.93 | 2,362,855 | |
| 11/08/2024 | 0.99 | 1.03 | 0.80 | 0.85 | 4,489,677 | |
| 11/07/2024 | 1.01 | 1.03 | 1.01 | 1.01 | 324,679 | |
| 11/06/2024 | 1.05 | 1.06 | 1.00 | 1.00 | 664,125 | |
| 11/05/2024 | 1.06 | 1.07 | 1.00 | 1.02 | 550,606 | |
| 11/04/2024 | 1.03 | 1.06 | 1.02 | 1.06 | 252,074 | |
| 11/01/2024 | 1.03 | 1.06 | 1.02 | 1.03 | 194,490 | |
| 10/31/2024 | 1.05 | 1.06 | 1.02 | 1.03 | 246,115 | |
| 10/30/2024 | 1.10 | 1.11 | 1.04 | 1.05 | 307,607 | |
| 10/29/2024 | 1.10 | 1.12 | 1.09 | 1.10 | 290,141 | |
| 10/28/2024 | 1.05 | 1.11 | 1.05 | 1.10 | 463,589 | |
| 10/25/2024 | 1.02 | 1.08 | 1.00 | 1.05 | 603,474 | |
| 10/24/2024 | 1.06 | 1.07 | 0.98 | 0.99 | 1,125,552 | |
| 10/23/2024 | 1.10 | 1.12 | 1.06 | 1.06 | 703,718 | |
| 10/22/2024 | 1.15 | 1.16 | 1.11 | 1.12 | 500,513 | |
| 10/21/2024 | 1.15 | 1.16 | 1.15 | 1.15 | 231,583 | |
| 10/18/2024 | 1.16 | 1.16 | 1.14 | 1.16 | 158,067 | |
| 10/17/2024 | 1.14 | 1.16 | 1.12 | 1.16 | 373,395 | |
| 10/16/2024 | 1.12 | 1.14 | 1.11 | 1.13 | 286,989 | |
| 10/15/2024 | 1.12 | 1.14 | 1.10 | 1.13 | 242,160 | |
| 10/14/2024 | 1.11 | 1.13 | 1.09 | 1.12 | 285,743 | |
| 10/11/2024 | 1.08 | 1.12 | 1.08 | 1.11 | 334,959 | |
| 10/10/2024 | 1.10 | 1.10 | 1.06 | 1.08 | 574,814 | |
| 10/09/2024 | 1.08 | 1.14 | 1.08 | 1.09 | 425,027 | |
| 10/08/2024 | 1.13 | 1.13 | 1.09 | 1.10 | 259,655 | |
| 10/07/2024 | 1.13 | 1.14 | 1.11 | 1.13 | 371,423 | |
| 10/04/2024 | 1.11 | 1.14 | 1.09 | 1.14 | 427,049 | |
| 10/03/2024 | 1.12 | 1.13 | 1.09 | 1.09 | 402,234 | |
| 10/02/2024 | 1.14 | 1.16 | 1.11 | 1.12 | 771,202 | |
| 10/01/2024 | 1.19 | 1.21 | 1.14 | 1.15 | 370,958 | |
| 09/30/2024 | 1.17 | 1.23 | 1.15 | 1.18 | 474,430 | |
| 09/27/2024 | 1.20 | 1.25 | 1.17 | 1.18 | 481,342 | |
| 09/26/2024 | 1.19 | 1.23 | 1.17 | 1.22 | 201,020 | |
| 09/25/2024 | 1.17 | 1.20 | 1.16 | 1.18 | 283,674 | |
| 09/24/2024 | 1.20 | 1.21 | 1.15 | 1.17 | 510,741 | |
| 09/23/2024 | 1.30 | 1.30 | 1.22 | 1.22 | 429,241 | |
| 09/20/2024 | 1.33 | 1.33 | 1.26 | 1.30 | 596,276 | |
| 09/19/2024 | 1.36 | 1.37 | 1.32 | 1.35 | 517,685 | |
| 09/18/2024 | 1.30 | 1.35 | 1.30 | 1.30 | 526,521 | |
| 09/17/2024 | 1.25 | 1.38 | 1.24 | 1.30 | 661,678 | |
| 09/16/2024 | 1.22 | 1.25 | 1.21 | 1.24 | 357,798 | |
| 09/13/2024 | 1.28 | 1.29 | 1.21 | 1.22 | 349,268 | |
| 09/12/2024 | 1.28 | 1.28 | 1.25 | 1.27 | 290,869 | |
| 09/11/2024 | 1.22 | 1.28 | 1.20 | 1.27 | 361,359 | |
| 09/10/2024 | 1.28 | 1.28 | 1.19 | 1.24 | 553,414 | |
| 09/09/2024 | 1.27 | 1.30 | 1.25 | 1.28 | 172,766 | |
| 09/06/2024 | 1.27 | 1.32 | 1.23 | 1.26 | 665,336 | |
| 09/05/2024 | 1.25 | 1.31 | 1.23 | 1.27 | 763,294 | |
| 09/04/2024 | 1.11 | 1.24 | 1.11 | 1.23 | 607,423 | |
| 09/03/2024 | 1.16 | 1.18 | 1.11 | 1.11 | 321,786 |
About Assertio Therapeutics Stock history
Assertio Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Assertio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Assertio Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Assertio Therapeutics stock prices may prove useful in developing a viable investing in Assertio Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 71 M | 74.6 M | |
| Net Income Applicable To Common Shares | 98.7 M | 103.6 M |
Assertio Therapeutics Stock Technical Analysis
Assertio Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Assertio Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Assertio Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Assertio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Assertio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (0.31) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.